Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
Harnett, Moore, and Hoke counties are under alert.
Breaking News
Severe thunderstorm warning issued for Hoke, Moore and Harnett counties until 11:15 p.m.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
223.19
-3.41 (-1.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
38
39
Next >
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
April 28, 2023
Here are three biotech stocks with promising innovations that could provide catalysts for their respective stocks in 2023
Via
InvestorPlace
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
April 26, 2023
The FDA approved Biogen Inc's (NASDAQ:
Via
Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $500 Today
April 26, 2023
Via
Benzinga
Biogen Earnings Perspective: Return On Capital Employed
April 26, 2023
Via
Benzinga
Alphabet To Rally Around 36%? Here Are 10 Other Analyst Forecasts For Wednesday
April 26, 2023
Morgan Stanley raised the price target for Alphabet Inc. (NASDAQ: GOOGL) from $135 to $140. Morgan Stanley analyst Brian Nowak maintained an Overweight rating. Alphabet shares fell 1% to $102.83 in...
Via
Benzinga
These Analysts Revise Price Targets On Biogen Following Q1 Results
April 26, 2023
Biogen Inc. (NASDAQ: BIIB) reported results for its first quarter.
Via
Benzinga
Biogen On The Hunt
April 25, 2023
Biogen is in the process of culling its pipeline to prepare for its upcoming deal making. What is happening and what does it mena?
Via
Talk Markets
Earnings Outlook For Biogen
April 24, 2023
Via
Benzinga
What Does Biogen's Debt Look Like?
April 19, 2023
Via
Benzinga
What's Going On With Biogen Stock Tuesday?
April 25, 2023
Biogen Inc (NASDAQ: BIIB) shares are trading lower Tuesday. The company reported first-quarter results before the bell and the FDA approved its ALS therapy Tuesday afternoon.
Via
Benzinga
Biogen Inc. Beats Q1 Earnings And Revenue Estimates
April 25, 2023
Biogen Inc. came out with quarterly earnings of $3.40 per share.
Via
Talk Markets
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
April 25, 2023
Via
Benzinga
Alzheimer's Drugs Still Aren't Biogen's Saving Grace — But The Company Is Hopeful
April 25, 2023
The company is hopeful for maintenance dosing and a new injection of the drug.
Via
Investor's Business Daily
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
All three companies have therapies with strong sales potential.
Via
The Motley Fool
Why Shares of Keros Therapeutics Jumped This Week
April 21, 2023
The company appointed a new director and an analyst reiterated his position on the stock.
Via
The Motley Fool
P/E Ratio Insights for Biogen
April 19, 2023
Via
Benzinga
Is Biogen Stock a Buy Now?
April 18, 2023
The company's fascinating saga in the Alzheimer's disease drug market continues.
Via
The Motley Fool
Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst
April 17, 2023
Via
Benzinga
Biogen To Report Q1 Earnings: Here's What To Expect
April 21, 2023
We expect Biogen to beat expectations when it reports first-quarter 2023 results on Apr. 25 before the market opens. In the last reported quarter, the company delivered an earnings surprise of 15.38%.
Via
Talk Markets
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
April 21, 2023
Eli Lilly And Co (NYSE: LLY) expects the U.S. Medicare health plan to loosen its grip on the coverage limits on new Alzheimer's drugs, as more data emerging in coming weeks show that clearing amyloid...
Via
Benzinga
Better Big Biotech Buy: Biogen vs. Vertex
April 20, 2023
One is slightly cheaper than the other.
Via
The Motley Fool
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
April 18, 2023
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.
Via
Benzinga
Biogen Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
April 17, 2023
Via
Benzinga
3 Stocks to Buy That Could Be the Next Biotech Breakthrough
April 16, 2023
Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.
Via
InvestorPlace
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.
Via
InvestorPlace
Biogen Moves Deeper In Alzheimer's With Denali
April 14, 2023
Biogen exercised their rights to a Denali Alzheimer's drug. What does this mean longer term to the field and the companies?
Via
Talk Markets
The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech
April 14, 2023
One executive called this the most "damaging" decision in five decades.
Via
Investor's Business Daily
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...
Via
Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.